For teams developing new treatments for gut inflammation, one of the biggest hurdles is identifying a preclinical model that truly fits the targeted disease and therapeutic strategy. Because no single model reflects the full complexity of human IBD, choosing the right approach depends on the question you want to answer. Acute models may help you screen for activity, while chronic or immune-mediated models allow you to explore mechanism, durability, or combination effects. Understanding these nuances early can accelerate decision-making and reduce unnecessary itearations.
In this service sheet, we introduce the spectrum of colitis models available at Oncodesign Services and explain how we support your project from model selection to data interpretation. By combining established protocols, reproducible endpoints, and translational expertise, we help researchers build solid, clinically relevant foundations for their IBD programs.
